Search results for "Head and Neck cancer"

showing 10 items of 124 documents

Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensu…

2012

Abstract Background Recent emerging evidences identify Human Papillomavirus (HPV) related Head and Neck squamous cell carcinomas (HN-SCCs) as a separate subgroup among Head and Neck Cancers with different epidemiology, histopathological characteristics, therapeutic response to chemo-radiation treatment and clinical outcome. However, there is not a worldwide consensus on the methods to be used in clinical practice. The endpoint of this study was to demonstrate the reliability of a triple method which combines evaluation of: 1. p16 protein expression by immunohistochemistry (p16-IHC); 2. HPV-DNA genotyping by consensus HPV-DNA PCR methods (Consensus PCR); and 3 viral integration into the host…

OncologyHuman papillomavirusHPVCancer Researchmedicine.medical_specialtyPathologyMethylation-Specific PCREpidemiologySettore MED/50 - Scienze Tecniche Mediche ApplicateBisulfite sequencingConsensus PCRIn situ hybridizationSettore MED/08 - Anatomia Patologicalcsh:RC254-282lcsh:Infectious and parasitic diseasesHPV-DNA; in situ hybridationSettore MED/28 - Malattie OdontostomatologicheInternal medicinemedicineDNA consensus PCRlcsh:RC109-216p16-IHCin situ hybridationGenotypingHN-SCCOPSCCbusiness.industryHead and neck cancerEpigeneticHPV-DNAHead and neck squamous cell carcinomalcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseImmunohistochemistryHead and neck squamous-cell carcinomastomatognathic diseasesInfectious DiseasesReal-time polymerase chain reactionOncologyImmunohistochemistryOSCCbusinessResearch ArticleIHCInfectious Agents and Cancer
researchProduct

Prevalence of HPV infection in racial-ethnic subgroups of head and neck cancer patients

2017

Abstract The landscape of human papillomavirus (HPV) infection in racial/ethnic subgroups of head and neck cancer (HNC) patients has not been evaluated carefully. In this study, a meta-analysis examined the prevalence of HPV in HNC patients of African ancestry. Additionally, a pooled analysis of subject-level data was also performed to investigate HPV prevalence and patterns of p16 (CDNK2A) expression amongst different racial groups. Eighteen publications (N = 798 Black HNC patients) were examined in the meta-analysis, and the pooled analysis included 29 datasets comprised of 3129 HNC patients of diverse racial/ethnic background. The meta-analysis revealed that the prevalence of HPV16 was h…

OncologyOROPHARYNGEAL CANCERHPVCancer Researchmedicine.medical_specialtyEthnic groupUNITED-STATESOriginal Manuscript03 medical and health sciences0302 clinical medicineInternal medicinemedicineP16 IMMUNOHISTOCHEMISTRYHuman papillomavirus030223 otorhinolaryngologyEPSTEIN-BARR-VIRUSE6/E7 MESSENGER-RNAAFRICAN-AMERICANSHUMAN-PAPILLOMAVIRUS TYPE-16IMPROVED SURVIVALbusiness.industryPOTENTIALLY MALIGNANT DISORDERSHead and neck cancerHPV infectionCancerOrvostudományokGeneral Medicinemedicine.diseaseRacial ethnic3. Good healthPooled analysis030220 oncology & carcinogenesisSmoking statusSettore MED/31 - OTORINOLARINGOIATRIASQUAMOUS-CELL CARCINOMAEgészségtudományokbusiness
researchProduct

Overexpression of ALDH1 and EMT marker profile are linked with unfavorable outcome in head and neck cancer

2020

Background The aim of this research was to assess the expression of aldehyde dehydrogenase 1 (ALDH1) and epithelial-mesenchymal transition (EMT) markers in head and neck squamous cell carcinoma (HNSCC), and to correlate them with the clinical and histopathological parameters of a patient cohort with follow-up over an 8-year period. Material and Methods For this, seventeen HNSCC and non-neoplastic adjacent epithelium (AE) samples were subjected to laser microdissection and real-time PCR to evaluate the mRNA expression of ALDH1, E-cadherin (E-CAD), N-cadherin (N-CAD), and vimentin (VIM). Also, immunohistochemistry was performed for ALDH1, E-CAD, N-CAD, and VIM in the tumor center (TC), invasi…

Oncologymedicine.medical_specialtyEpithelial-Mesenchymal Transitionmedicine.medical_treatmentVimentinAldehyde Dehydrogenase 1 FamilyMetastasis03 medical and health sciences0302 clinical medicineInternal medicineBiomarkers TumormedicineHumansEpithelial–mesenchymal transitionGeneral DentistryLaser capture microdissectionOral Medicine and PathologybiologySquamous Cell Carcinoma of Head and Neckbusiness.industryResearchHead and neck cancer030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Head and neck squamous-cell carcinomaRadiation therapyOtorhinolaryngologyHead and Neck NeoplasmsUNESCO::CIENCIAS MÉDICASbiology.proteinImmunohistochemistrySurgeryNeoplasm Recurrence Localbusiness
researchProduct

Periodontitis as a risk factor for head and neck cancer

2020

Background Periodontitis may be associated with the development of head and neck cancer (HNC). A literature review was conducted to understand the possible association between them. Material and Methods Articles published in the PubMed database from January 1999 and May 2020 were retrieved. Limitations of the studies and biological mechanisms were discussed. Results A total of 4,232 articles were found. Of these, 13 were analyzed according to inclusion criteria. Most papers found some association between periodontitis and HNC, although differences in periodontal evaluation, sample size, study design and tumor sites were observed. Porphyromonas gingivalis appears to increase the chance of bo…

Oncologymedicine.medical_specialtyMEDLINEReviewRisk FactorsInternal medicinemedicineGenetic predispositionHumansPeriodontologyRisk factorPeriodontitisGeneral DentistryPorphyromonas gingivalissolid organ transplantationUNESCO:CIENCIAS MÉDICASPeriodontitisbiologyPotential riskbusiness.industryHead and neck cancermedicine.diseaseOmicsbiology.organism_classificationOtorhinolaryngologyHead and Neck Neoplasmsoral healthoral health-related quality of lifeSurgerybusinessPorphyromonas gingivalis
researchProduct

HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007).

2008

Abstract INTRODUCTION: In the literature, there exists a wide range of human papillomavirus (HPV) DNA prevalence for head and neck squamous cell carcinoma (HNSCC), especially in relation to methods of viral detection and the lesion site. We estimated the pooled prevalence of HPV DNA in biopsies of HNSCC generically grouped versus oral squamous cell carcinoma (OSCC) in relation to the method of viral DNA detection, with the primary end point of verifying if these two variables (specification of tumour site and method of HPV DNA identification) influence the datum on HPV assay. METHODS: By means of MEDLINE/PubMED/Ovid databases, we selected studies examining paraffin-embedded (PE) biopsies of…

Oncologymedicine.medical_specialtyPathologyHPV/ oral squamous cell carcinoma/ head and neck squamous cell carcinomaSettore MED/06 - Oncologia MedicaBiopsySettore MED/50 - Scienze Tecniche Mediche ApplicatePolymerase Chain ReactionSettore MED/01 - Statistica Medicalaw.inventionlawInternal medicineBiopsymedicineCarcinomaHumansPapillomaviridaePolymerase chain reactionIn Situ Hybridizationmedicine.diagnostic_testbusiness.industryHead and neck cancerPapillomavirus InfectionsCancerAnatomical pathologyHematologymedicine.diseaseHead and neck squamous-cell carcinomastomatognathic diseasesOncologyHead and Neck NeoplasmsDNA ViralCarcinoma Squamous CellMouth NeoplasmsViral diseasebusinessAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC)

2017

Oncologymedicine.medical_specialtyPrognostic factorIndex (economics)business.industryHead and neck cancerCellHematologymedicine.diseaseHead and neck squamous-cell carcinomamedicine.anatomical_structureOncologyInternal medicinemedicinebusinessPrognostic Nutritional Index (PNI)
researchProduct

The combined effect of fludarabine monophosphate and radiation as well as gemcitabine and radiation on squamous carcinoma tumor cell lines in vitro.

2008

Despite proven antitumor activity of gemcitabine in chemoradiotherapy of advanced head and neck cancer, many authors refer to severe acute and late local and haematological toxicity. Fludarabine does imply nearly the same mechanisms of action as gemcitabine, inhibiting various enzymes involved in DNA replication. This investigation focuses on the combined effect of either fludarabine or gemcitabine and radiation on human squamous carcinoma cell lines in vitro, providing data for future decisions on head and neck chemoradiotherapy regimen.ZMK-1, A549, BW-225, GR-145, OH-65 and CaSki cell lines were incubated with either drug at defined schedules and irradiated at a single fraction dose of 2 …

Oncologymedicine.medical_specialtyRadiation-Sensitizing AgentsCell SurvivalApoptosisDeoxycytidine03 medical and health sciences0302 clinical medicineFludarabine monophosphateInternal medicineCell Line TumormedicineCarcinomaHumansRadiology Nuclear Medicine and imaging030304 developmental biology0303 health sciencesRadiological and Ultrasound Technologybusiness.industryHead and neck cancermedicine.diseaseGemcitabineGemcitabine3. Good healthFludarabineSquamous carcinomaApoptosis030220 oncology & carcinogenesisCarcinoma Squamous CellbusinessVidarabine PhosphateChemoradiotherapymedicine.drugInternational journal of radiation biology
researchProduct

Cetuximab in squamous cell head and neck carcinomas.

2007

The epidermal growth factor receptor (EGFR) antagonist, cetuximab, has recently been shown to enhance the effects of radiotherapy, and reports to date indicate that this effect occurs without any change in the pattern and severity of toxicity usually associated with head and neck radiation and/or chemotherapy (CT) administration. Moreover, several studies have reported that the expression of EGFR is strongly linked to poor outcome in patients undergoing therapy. Therefore, the presence of the EGFR in almost all cases of head and neck carcinoma offers a new therapeutic opportunity to most patients. In this paper, we report a review of the major studies dealing with the use of cetuximab in ad…

Oncologymedicine.medical_specialtyRadiation-Sensitizing Agentsmedicine.medical_treatmentCetuximabAntineoplastic AgentsAntibodies Monoclonal HumanizedClinical Trials Phase II as TopicInternal medicinemedicineCarcinomaAnimalsHumansEpidermal growth factor receptorSquamous epithelial cellCetuximabbiologyClinical Trials Phase I as Topicbusiness.industryHead and neck cancerAntibodies MonoclonalHematologymedicine.diseaseHead and neck squamous-cell carcinomaChemotherapy regimenRadiation therapyneck carcinomasmedicine.anatomical_structureOncologyHead and Neck Neoplasmsbiology.proteinCarcinoma Squamous CellNeoplasm Recurrence Localbusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Salivary Cytokines in patients with Head and Neck Cancer (HNC) treated with Radiotherapy.

2019

Background Head and Neck cancer (HNC) is the sixth most common cancer in the world. The 5-year survival rate depends on early diagnosis and appropriate therapy. Typically, late diagnosis requires not only surgical intervention, but also radiotherapy treatment combined or not with chemotherapy. Ionizing radiation is known to increase the expression of a number of cytokines involved in inflammation, wound healing and toxicity areas. Salivary cytokines have promising features to be used as biomarkers for disease screening and outcome prediction in this malignancy. The aim of this article is to analyze the role of salivary inflammatory response elements in HNC patients treated with radiotherapy…

Oncologymedicine.medical_specialtySalivamedicine.medical_treatmentReviewMalignancy03 medical and health sciences0302 clinical medicineInternal medicinemedicineGeneral DentistrySurvival rateChemotherapyOral Medicine and Pathologybusiness.industryHead and neck cancerCancer030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]3. Good healthRadiation therapy030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASBiomarker (medicine)businessJournal of clinical and experimental dentistry
researchProduct

Non-invasive diagnosis of oral cancer: The role of electro-analytical methods and nanomaterials

2017

Abstract Oral cancer is a kind of head and neck cancer and is each cancerous tissue growth located in the oral cavity. Non-invasive early diagnosis of oral cancer is the most effective means to reduce death from this disease or increase the survival time. In this review, various types of electro-analytical methods for detection of oral cancer were discussed. The emphasis is placed on non-invasive detection of oral based on immune-, geno-, cyto-, apta-, and enzyme-biosensing strategies. In the first part of review, various electrochemical immunosensing methods for the detection of common biomarker in oral cancer and examines their potential as a new method were discussed. In the second part …

Oncologymedicine.medical_specialtybusiness.industry010401 analytical chemistryHead and neck cancerNon invasiveCancerNanotechnology02 engineering and technologyDisease021001 nanoscience & nanotechnologymedicine.diseaseOral cavity01 natural sciences0104 chemical sciencesAnalytical ChemistryBiomarker (cell)stomatognathic diseasesInternal medicinemedicineElectrochemical biosensor0210 nano-technologybusinessSpectroscopyBiomedicineTrAC Trends in Analytical Chemistry
researchProduct